

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.10783734 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.10783734 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.97261986 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.80264103 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.27247132 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.20477026 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.09316261 |
| 8 | detection of other organism (GO:0098543) | 4.91983054 |
| 9 | detection of bacterium (GO:0016045) | 4.82680016 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.78793690 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.67832527 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 4.59498013 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.50156651 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.50156651 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.47942645 |
| 16 | response to peptidoglycan (GO:0032494) | 4.40631673 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 4.29370030 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.04489325 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.02648763 |
| 20 | regulation of B cell differentiation (GO:0045577) | 4.01588807 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94575546 |
| 22 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.86096574 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.75499664 |
| 24 | negative thymic T cell selection (GO:0045060) | 3.74170407 |
| 25 | response to interleukin-15 (GO:0070672) | 3.74118176 |
| 26 | thymic T cell selection (GO:0045061) | 3.73121403 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.73101821 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69546777 |
| 29 | negative T cell selection (GO:0043383) | 3.67651994 |
| 30 | respiratory burst (GO:0045730) | 3.67025151 |
| 31 | leukocyte aggregation (GO:0070486) | 3.62125699 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.58481244 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57647820 |
| 34 | angiogenesis involved in wound healing (GO:0060055) | 3.57563714 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.57118833 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.55993467 |
| 37 | response to host immune response (GO:0052572) | 3.55993467 |
| 38 | detection of biotic stimulus (GO:0009595) | 3.52842466 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51393741 |
| 40 | granulocyte activation (GO:0036230) | 3.50339669 |
| 41 | positive T cell selection (GO:0043368) | 3.45117718 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.45074597 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.45057530 |
| 44 | germinal center formation (GO:0002467) | 3.45020285 |
| 45 | T cell selection (GO:0045058) | 3.44829982 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.43055112 |
| 47 | tolerance induction (GO:0002507) | 3.42821687 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.40647443 |
| 49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40306680 |
| 50 | hepatocyte apoptotic process (GO:0097284) | 3.39869256 |
| 51 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.36831390 |
| 52 | response to host (GO:0075136) | 3.34607383 |
| 53 | response to host defenses (GO:0052200) | 3.34607383 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.34607383 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.33950416 |
| 56 | microglial cell activation (GO:0001774) | 3.32400709 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.31919477 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 3.31024224 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.30009610 |
| 60 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27329396 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25779850 |
| 62 | macrophage activation (GO:0042116) | 3.25539238 |
| 63 | negative regulation of granulocyte differentiation (GO:0030853) | 3.20349712 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20267179 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.19699357 |
| 66 | mature B cell differentiation (GO:0002335) | 3.18482708 |
| 67 | interferon-gamma production (GO:0032609) | 3.16133562 |
| 68 | positive regulation of mast cell activation (GO:0033005) | 3.15173385 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 3.14539951 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 3.10931306 |
| 71 | positive regulation of antigen processing and presentation (GO:0002579) | 3.10899966 |
| 72 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.10138924 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.08397731 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.07008175 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.05549432 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 3.04570889 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.04277289 |
| 78 | megakaryocyte development (GO:0035855) | 3.03113643 |
| 79 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.02538150 |
| 80 | mast cell activation (GO:0045576) | 3.02514067 |
| 81 | positive regulation of lamellipodium assembly (GO:0010592) | 3.01730787 |
| 82 | definitive hemopoiesis (GO:0060216) | 3.01398954 |
| 83 | response to protozoan (GO:0001562) | 3.00635723 |
| 84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00030747 |
| 85 | leukocyte cell-cell adhesion (GO:0007159) | 2.99150255 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.98110625 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.98110625 |
| 88 | macrophage activation involved in immune response (GO:0002281) | 2.97709979 |
| 89 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96695734 |
| 90 | response to muramyl dipeptide (GO:0032495) | 2.95710975 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95641113 |
| 92 | T cell homeostasis (GO:0043029) | 2.94937575 |
| 93 | positive regulation of histone deacetylation (GO:0031065) | 2.94736524 |
| 94 | lymphocyte homeostasis (GO:0002260) | 2.90157434 |
| 95 | NIK/NF-kappaB signaling (GO:0038061) | 2.90004624 |
| 96 | T cell migration (GO:0072678) | 2.89888095 |
| 97 | negative regulation of innate immune response (GO:0045824) | 2.89831986 |
| 98 | neutrophil mediated immunity (GO:0002446) | 2.89649501 |
| 99 | response to type I interferon (GO:0034340) | 2.89076833 |
| 100 | leukocyte degranulation (GO:0043299) | 2.89053708 |
| 101 | cellular extravasation (GO:0045123) | 2.89004377 |
| 102 | defense response to protozoan (GO:0042832) | 2.88921403 |
| 103 | endothelial tube morphogenesis (GO:0061154) | 2.86195631 |
| 104 | morphogenesis of an endothelium (GO:0003159) | 2.86195631 |
| 105 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85395476 |
| 106 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85002023 |
| 107 | negative regulation of interleukin-6 production (GO:0032715) | 2.84988518 |
| 108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83904334 |
| 109 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83348587 |
| 110 | ribosomal small subunit assembly (GO:0000028) | 2.83160501 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 2.83026332 |
| 112 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83016255 |
| 113 | negative regulation of type 2 immune response (GO:0002829) | 2.82888583 |
| 114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81962179 |
| 115 | regulation of regulated secretory pathway (GO:1903305) | 2.81943392 |
| 116 | positive regulation of mast cell degranulation (GO:0043306) | 2.81857161 |
| 117 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81857161 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.81825456 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.81825456 |
| 120 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81718388 |
| 121 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81718388 |
| 122 | modulation by symbiont of host immune response (GO:0052553) | 2.81718388 |
| 123 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81718388 |
| 124 | modulation by symbiont of host defense response (GO:0052031) | 2.81718388 |
| 125 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81718388 |
| 126 | positive regulation of lamellipodium organization (GO:1902745) | 2.81088563 |
| 127 | myeloid cell activation involved in immune response (GO:0002275) | 2.80100160 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.80048062 |
| 129 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74774693 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 2.74452927 |
| 131 | natural killer cell differentiation (GO:0001779) | 2.73675075 |
| 132 | neutrophil activation (GO:0042119) | 2.72610744 |
| 133 | T cell costimulation (GO:0031295) | 2.71579276 |
| 134 | negative regulation of bone resorption (GO:0045779) | 2.70924375 |
| 135 | regulation of response to interferon-gamma (GO:0060330) | 2.69461546 |
| 136 | positive regulation of interferon-alpha production (GO:0032727) | 2.68741683 |
| 137 | cellular response to zinc ion (GO:0071294) | 2.67254125 |
| 138 | lymphocyte costimulation (GO:0031294) | 2.66078077 |
| 139 | response to laminar fluid shear stress (GO:0034616) | 2.65669783 |
| 140 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.65496158 |
| 141 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.64306864 |
| 142 | B cell homeostasis (GO:0001782) | 2.63344363 |
| 143 | B cell mediated immunity (GO:0019724) | 2.62641335 |
| 144 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.61981445 |
| 145 | positive regulation of macrophage differentiation (GO:0045651) | 2.61888768 |
| 146 | leukocyte homeostasis (GO:0001776) | 2.60259147 |
| 147 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59349317 |
| 148 | regulation of interferon-alpha production (GO:0032647) | 2.57300947 |
| 149 | regulation of granulocyte differentiation (GO:0030852) | 2.57272774 |
| 150 | regulation of erythrocyte differentiation (GO:0045646) | 2.56598474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.28898145 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.07379355 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00471415 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.55319658 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27001394 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.24151074 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.07095200 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02714954 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.00611808 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84546265 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79879193 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66680676 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62297926 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.59650050 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.59357295 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58687365 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54497537 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54139474 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.48274077 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.45136220 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.44993201 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42010822 |
| 23 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41284646 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39947106 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38075912 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.37225464 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.27077132 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24783949 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20750588 |
| 30 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.19752908 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19381335 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.14122962 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13618516 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07081428 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04182608 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03052254 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.02467279 |
| 38 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.00241984 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97050345 |
| 40 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88492497 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87574639 |
| 42 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.87329510 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.80927725 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72478862 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69932983 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66661498 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.59108547 |
| 48 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58426964 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54587495 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51467394 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47763600 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46019264 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45874204 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43529501 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42328935 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37591912 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36479237 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34347900 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33357457 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32475841 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30624534 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27784906 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27565350 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27523450 |
| 65 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24941785 |
| 66 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.23774303 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23746808 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23344572 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21172183 |
| 70 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19225182 |
| 71 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16325498 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13785592 |
| 73 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12381445 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11664551 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11431644 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11341901 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10649269 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.10431369 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09835306 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09819247 |
| 81 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09242201 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07390542 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05894849 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04909371 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04740949 |
| 86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04714981 |
| 87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04542958 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04337426 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03447085 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02210807 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98641258 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97907540 |
| 93 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97706790 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96159083 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 0.95440977 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94000577 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.93652097 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91250571 |
| 99 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90298455 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89438149 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89296042 |
| 102 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.88469250 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88065603 |
| 104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87767679 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87322745 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86964018 |
| 107 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86822327 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86816407 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86604996 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86122088 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84913650 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82680137 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81601117 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81097186 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80780220 |
| 116 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80764323 |
| 117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80058858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.62216181 |
| 2 | MP0000685_abnormal_immune_system | 3.02355627 |
| 3 | MP0005671_abnormal_response_to | 2.99742455 |
| 4 | MP0001800_abnormal_humoral_immune | 2.89291548 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.79306210 |
| 6 | MP0003303_peritoneal_inflammation | 2.77412551 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.68852112 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.68488172 |
| 9 | MP0001873_stomach_inflammation | 2.67770493 |
| 10 | MP0005387_immune_system_phenotype | 2.67143866 |
| 11 | MP0001790_abnormal_immune_system | 2.67143866 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.56606414 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.42656683 |
| 14 | MP0001819_abnormal_immune_cell | 2.40887669 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.40425397 |
| 16 | MP0002723_abnormal_immune_serum | 2.39875494 |
| 17 | MP0009785_altered_susceptibility_to | 2.31765593 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.30407611 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.28768809 |
| 20 | MP0003866_abnormal_defecation | 2.27757112 |
| 21 | MP0003436_decreased_susceptibility_to | 2.26804965 |
| 22 | MP0005025_abnormal_response_to | 2.25426768 |
| 23 | MP0002398_abnormal_bone_marrow | 2.23627491 |
| 24 | MP0009278_abnormal_bone_marrow | 2.17891044 |
| 25 | MP0004510_myositis | 2.17273027 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.11670182 |
| 27 | MP0002419_abnormal_innate_immunity | 2.09709976 |
| 28 | MP0000716_abnormal_immune_system | 2.04003096 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.99178023 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.98166149 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.92431560 |
| 32 | MP0002405_respiratory_system_inflammati | 1.90292085 |
| 33 | MP0004947_skin_inflammation | 1.89936272 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.88476575 |
| 35 | MP0002722_abnormal_immune_system | 1.85821477 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.85818990 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.85818990 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.82951806 |
| 39 | MP0003724_increased_susceptibility_to | 1.82775332 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.76516739 |
| 41 | MP0008260_abnormal_autophagy | 1.76487923 |
| 42 | MP0002429_abnormal_blood_cell | 1.74119985 |
| 43 | MP0006082_CNS_inflammation | 1.72543353 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.71761284 |
| 45 | MP0005451_abnormal_body_composition | 1.71113043 |
| 46 | MP0002006_tumorigenesis | 1.66923842 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.64329847 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.57711352 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.55860627 |
| 50 | MP0001853_heart_inflammation | 1.53564905 |
| 51 | MP0000490_abnormal_crypts_of | 1.50927283 |
| 52 | MP0002132_abnormal_respiratory_system | 1.44960194 |
| 53 | MP0003828_pulmonary_edema | 1.43953094 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.41138334 |
| 55 | MP0001879_abnormal_lymphatic_vessel | 1.35269828 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.34424464 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.34019537 |
| 58 | MP0005310_abnormal_salivary_gland | 1.30703897 |
| 59 | MP0004381_abnormal_hair_follicle | 1.28582498 |
| 60 | MP0010368_abnormal_lymphatic_system | 1.27205885 |
| 61 | MP0006054_spinal_hemorrhage | 1.20691317 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.18681076 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.17063908 |
| 64 | MP0004883_abnormal_blood_vessel | 1.16593390 |
| 65 | MP0008469_abnormal_protein_level | 1.16349400 |
| 66 | MP0001851_eye_inflammation | 1.14536821 |
| 67 | MP0001663_abnormal_digestive_system | 1.14127175 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.10224742 |
| 69 | MP0000858_altered_metastatic_potential | 1.09823763 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.09069786 |
| 71 | MP0003448_altered_tumor_morphology | 1.07261031 |
| 72 | MP0002933_joint_inflammation | 1.07187511 |
| 73 | MP0000343_altered_response_to | 1.04722172 |
| 74 | MP0003045_fibrosis | 1.04631466 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.04487143 |
| 76 | MP0005023_abnormal_wound_healing | 1.01179914 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.96712664 |
| 78 | MP0000249_abnormal_blood_vessel | 0.94243715 |
| 79 | MP0005164_abnormal_response_to | 0.93071454 |
| 80 | MP0005166_decreased_susceptibility_to | 0.93061864 |
| 81 | MP0003690_abnormal_glial_cell | 0.90869326 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 0.90077873 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.88190311 |
| 84 | MP0000477_abnormal_intestine_morphology | 0.86981390 |
| 85 | MP0005390_skeleton_phenotype | 0.86507934 |
| 86 | MP0003075_altered_response_to | 0.85593432 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.85588685 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.85457576 |
| 89 | MP0008004_abnormal_stomach_pH | 0.85086050 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.84835786 |
| 91 | MP0009840_abnormal_foam_cell | 0.84691393 |
| 92 | MP0003091_abnormal_cell_migration | 0.83545820 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.81456360 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.80447759 |
| 95 | MP0009763_increased_sensitivity_to | 0.78111645 |
| 96 | MP0000604_amyloidosis | 0.74903963 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.73561913 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.71183604 |
| 99 | MP0002928_abnormal_bile_duct | 0.68031878 |
| 100 | MP0002009_preneoplasia | 0.67172116 |
| 101 | MP0005381_digestive/alimentary_phenotyp | 0.66296511 |
| 102 | MP0009764_decreased_sensitivity_to | 0.65878493 |
| 103 | MP0001986_abnormal_taste_sensitivity | 0.64209510 |
| 104 | MP0003795_abnormal_bone_structure | 0.64113187 |
| 105 | MP0001958_emphysema | 0.63768862 |
| 106 | MP0010307_abnormal_tumor_latency | 0.63314849 |
| 107 | MP0001216_abnormal_epidermal_layer | 0.62138457 |
| 108 | MP0003279_aneurysm | 0.59073769 |
| 109 | MP0008874_decreased_physiological_sensi | 0.59024377 |
| 110 | MP0008873_increased_physiological_sensi | 0.58111882 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.57762380 |
| 112 | MP0001191_abnormal_skin_condition | 0.57718696 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.57191705 |
| 114 | MP0005165_increased_susceptibility_to | 0.56904176 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.56468536 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.56302905 |
| 117 | MP0005083_abnormal_biliary_tract | 0.55272227 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.53501406 |
| 119 | MP0000609_abnormal_liver_physiology | 0.53351699 |
| 120 | MP0005360_urolithiasis | 0.53140885 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.52514826 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.52389602 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.52114111 |
| 124 | MP0002254_reproductive_system_inflammat | 0.51353167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 4.36797900 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.24253732 |
| 3 | Recurrent viral infections (HP:0004429) | 4.11398981 |
| 4 | Spontaneous hematomas (HP:0007420) | 4.07275318 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.04983141 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.04322774 |
| 7 | Chronic otitis media (HP:0000389) | 4.02192613 |
| 8 | Colitis (HP:0002583) | 3.96301780 |
| 9 | Inflammation of the large intestine (HP:0002037) | 3.91323901 |
| 10 | Hematochezia (HP:0002573) | 3.88506770 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85786434 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 3.85522286 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.85083961 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 3.79032013 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.76537426 |
| 16 | Myositis (HP:0100614) | 3.66743771 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65483893 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.59287715 |
| 19 | Cellulitis (HP:0100658) | 3.52910186 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.50438567 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.45695113 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.44705609 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 3.42169718 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32226453 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32226453 |
| 26 | Thrombocytosis (HP:0001894) | 3.31064524 |
| 27 | Abnormality of the fingertips (HP:0001211) | 3.28961299 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.25257083 |
| 29 | T lymphocytopenia (HP:0005403) | 3.22921210 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.21966870 |
| 31 | Chronic diarrhea (HP:0002028) | 3.21385238 |
| 32 | Urticaria (HP:0001025) | 3.21220569 |
| 33 | Increased IgE level (HP:0003212) | 3.19768616 |
| 34 | Pustule (HP:0200039) | 3.15934017 |
| 35 | Abnormality of T cells (HP:0002843) | 3.11416913 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.08771845 |
| 37 | Abnormality of B cell number (HP:0010975) | 3.07819785 |
| 38 | B lymphocytopenia (HP:0010976) | 3.07819785 |
| 39 | Nasal polyposis (HP:0100582) | 3.07778057 |
| 40 | Meningitis (HP:0001287) | 3.07277897 |
| 41 | Gastrointestinal stroma tumor (HP:0100723) | 3.06468669 |
| 42 | Lymphopenia (HP:0001888) | 3.00710353 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.91932882 |
| 44 | Recurrent skin infections (HP:0001581) | 2.89233026 |
| 45 | Thyroiditis (HP:0100646) | 2.85553629 |
| 46 | Papilloma (HP:0012740) | 2.83929976 |
| 47 | Verrucae (HP:0200043) | 2.83929976 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.82888167 |
| 49 | Petechiae (HP:0000967) | 2.81347478 |
| 50 | Vasculitis (HP:0002633) | 2.76394110 |
| 51 | Hypochromic anemia (HP:0001931) | 2.76346411 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.64961928 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.60735417 |
| 54 | Episodic fever (HP:0001954) | 2.57655669 |
| 55 | Impaired platelet aggregation (HP:0003540) | 2.56975279 |
| 56 | Abnormal platelet function (HP:0011869) | 2.56975279 |
| 57 | Gingival bleeding (HP:0000225) | 2.56524596 |
| 58 | Cerebral aneurysm (HP:0004944) | 2.54654640 |
| 59 | Emphysema (HP:0002097) | 2.53796071 |
| 60 | Increased IgM level (HP:0003496) | 2.53742128 |
| 61 | Amyloidosis (HP:0011034) | 2.53549385 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.53034480 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.51334217 |
| 64 | Eosinophilia (HP:0001880) | 2.49081114 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.46440417 |
| 66 | IgA deficiency (HP:0002720) | 2.44724777 |
| 67 | Pulmonary embolism (HP:0002204) | 2.41545426 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40344695 |
| 69 | Obstructive lung disease (HP:0006536) | 2.40344695 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.39407064 |
| 71 | Hemoptysis (HP:0002105) | 2.38203814 |
| 72 | Osteomyelitis (HP:0002754) | 2.37004854 |
| 73 | Anorexia (HP:0002039) | 2.36159931 |
| 74 | Malnutrition (HP:0004395) | 2.33875869 |
| 75 | Abnormality of eosinophils (HP:0001879) | 2.32251783 |
| 76 | Recurrent sinusitis (HP:0011108) | 2.31207375 |
| 77 | Orchitis (HP:0100796) | 2.28607395 |
| 78 | Granulocytopenia (HP:0001913) | 2.28289820 |
| 79 | Loss of speech (HP:0002371) | 2.25528105 |
| 80 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24808603 |
| 81 | Aortic aneurysm (HP:0004942) | 2.24633790 |
| 82 | Chronic sinusitis (HP:0011109) | 2.24367104 |
| 83 | IgG deficiency (HP:0004315) | 2.23442855 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.23294027 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.23229294 |
| 86 | Skin ulcer (HP:0200042) | 2.23146701 |
| 87 | Polycythemia (HP:0001901) | 2.22919554 |
| 88 | Combined immunodeficiency (HP:0005387) | 2.22402086 |
| 89 | Leukocytosis (HP:0001974) | 2.21569345 |
| 90 | Chest pain (HP:0100749) | 2.19229418 |
| 91 | Peritonitis (HP:0002586) | 2.19036358 |
| 92 | Gangrene (HP:0100758) | 2.17983053 |
| 93 | Epistaxis (HP:0000421) | 2.17492661 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17229618 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17229618 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17229618 |
| 97 | Sepsis (HP:0100806) | 2.11628879 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10454586 |
| 99 | Restrictive lung disease (HP:0002091) | 2.10323278 |
| 100 | Stomatitis (HP:0010280) | 2.06984323 |
| 101 | Bronchitis (HP:0012387) | 2.06868792 |
| 102 | Bicuspid aortic valve (HP:0001647) | 2.05752144 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.04407176 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.03149944 |
| 105 | Increased serum ferritin (HP:0003281) | 2.01684598 |
| 106 | Purpura (HP:0000979) | 2.00866502 |
| 107 | Viral hepatitis (HP:0006562) | 2.00648759 |
| 108 | Fatigue (HP:0012378) | 1.99145713 |
| 109 | Cheilitis (HP:0100825) | 1.98619958 |
| 110 | Periodontitis (HP:0000704) | 1.97719778 |
| 111 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97396284 |
| 112 | Abnormality of the endocardium (HP:0004306) | 1.95808322 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.95099708 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.94167294 |
| 115 | Vacuolated lymphocytes (HP:0001922) | 1.93631844 |
| 116 | Microcytic anemia (HP:0001935) | 1.93017201 |
| 117 | Arterial thrombosis (HP:0004420) | 1.92937129 |
| 118 | Gingivitis (HP:0000230) | 1.92674437 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 1.92578475 |
| 120 | Lymphoma (HP:0002665) | 1.92280616 |
| 121 | Glomerulopathy (HP:0100820) | 1.91757361 |
| 122 | Skin rash (HP:0000988) | 1.91305383 |
| 123 | Urethral obstruction (HP:0000796) | 1.89056778 |
| 124 | Increased cerebral lipofuscin (HP:0011813) | 1.86121214 |
| 125 | Encephalitis (HP:0002383) | 1.85803149 |
| 126 | Pulmonary infiltrates (HP:0002113) | 1.84997873 |
| 127 | Abnormal platelet volume (HP:0011876) | 1.84387485 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.82586152 |
| 129 | Poikiloderma (HP:0001029) | 1.80027918 |
| 130 | Optic neuritis (HP:0100653) | 1.79139021 |
| 131 | Retrobulbar optic neuritis (HP:0100654) | 1.79139021 |
| 132 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75939935 |
| 133 | Ureteral stenosis (HP:0000071) | 1.75811545 |
| 134 | Facial diplegia (HP:0001349) | 1.73189767 |
| 135 | Recurrent pneumonia (HP:0006532) | 1.71894538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.04007937 |
| 2 | TGFBR2 | 3.85253119 |
| 3 | TYK2 | 2.59129362 |
| 4 | EEF2K | 2.57649869 |
| 5 | PRPF4B | 2.55667702 |
| 6 | STK10 | 2.29480476 |
| 7 | CSF1R | 2.23343525 |
| 8 | MAP3K10 | 2.21451148 |
| 9 | ERN1 | 2.19329273 |
| 10 | ZAP70 | 2.15903291 |
| 11 | TIE1 | 2.09090542 |
| 12 | BLK | 2.06797069 |
| 13 | KIT | 2.04403656 |
| 14 | TXK | 2.04143366 |
| 15 | GRK6 | 2.00563720 |
| 16 | PKN2 | 1.96781360 |
| 17 | JAK3 | 1.94416944 |
| 18 | BTK | 1.91629124 |
| 19 | KDR | 1.91111519 |
| 20 | TGFBR1 | 1.88779042 |
| 21 | TBK1 | 1.84034759 |
| 22 | ITK | 1.79353341 |
| 23 | LRRK2 | 1.77535040 |
| 24 | MAP2K3 | 1.67504130 |
| 25 | EPHB1 | 1.67434847 |
| 26 | JAK1 | 1.62700588 |
| 27 | TEC | 1.59696443 |
| 28 | SYK | 1.57534458 |
| 29 | RIPK4 | 1.56430897 |
| 30 | FGR | 1.51833434 |
| 31 | IKBKE | 1.49422081 |
| 32 | FES | 1.41122045 |
| 33 | SIK2 | 1.41091252 |
| 34 | TRIB3 | 1.40525169 |
| 35 | FGFR4 | 1.39136639 |
| 36 | HCK | 1.38048129 |
| 37 | MAP3K14 | 1.37538633 |
| 38 | LCK | 1.27371847 |
| 39 | PTK6 | 1.27265103 |
| 40 | MAP3K1 | 1.25318326 |
| 41 | CSK | 1.23628695 |
| 42 | IRAK4 | 1.23586322 |
| 43 | FLT3 | 1.22528949 |
| 44 | RIPK1 | 1.20874761 |
| 45 | PAK4 | 1.19733492 |
| 46 | MST4 | 1.19636907 |
| 47 | SMG1 | 1.18415408 |
| 48 | FGFR3 | 1.11983458 |
| 49 | MARK2 | 1.09630120 |
| 50 | MAP3K13 | 1.07011099 |
| 51 | NME2 | 1.04063688 |
| 52 | PRKD2 | 0.98437209 |
| 53 | CDC42BPA | 0.95435410 |
| 54 | PIM1 | 0.95282939 |
| 55 | IRAK3 | 0.94840374 |
| 56 | CLK1 | 0.94801580 |
| 57 | KSR2 | 0.93886818 |
| 58 | NLK | 0.92563590 |
| 59 | RPS6KA4 | 0.90747537 |
| 60 | LYN | 0.87650789 |
| 61 | YES1 | 0.87312591 |
| 62 | MARK3 | 0.85712470 |
| 63 | IRAK1 | 0.84697643 |
| 64 | PDPK1 | 0.84433226 |
| 65 | TTN | 0.83676313 |
| 66 | TESK2 | 0.83095629 |
| 67 | IKBKB | 0.82898669 |
| 68 | MATK | 0.82826852 |
| 69 | RPS6KB2 | 0.82155426 |
| 70 | PRKG2 | 0.80095667 |
| 71 | TAOK2 | 0.79838844 |
| 72 | MAP3K7 | 0.76825386 |
| 73 | PIM2 | 0.75784685 |
| 74 | JAK2 | 0.73784804 |
| 75 | BMPR2 | 0.73055121 |
| 76 | MAP2K2 | 0.70858293 |
| 77 | IRAK2 | 0.67326124 |
| 78 | DMPK | 0.66004656 |
| 79 | MAPKAPK3 | 0.65667731 |
| 80 | MAP3K6 | 0.65282584 |
| 81 | TAOK1 | 0.65108859 |
| 82 | CDK12 | 0.63604115 |
| 83 | TSSK6 | 0.63102304 |
| 84 | SCYL2 | 0.63030923 |
| 85 | SIK3 | 0.62614832 |
| 86 | MAP3K2 | 0.60979142 |
| 87 | PDK1 | 0.60943081 |
| 88 | MAP2K6 | 0.60907135 |
| 89 | TRPM7 | 0.60737745 |
| 90 | TNK2 | 0.60518187 |
| 91 | FYN | 0.59981951 |
| 92 | CAMK1D | 0.59235508 |
| 93 | MAP3K3 | 0.58226233 |
| 94 | CHUK | 0.57564171 |
| 95 | MAP3K8 | 0.57077163 |
| 96 | MAP3K11 | 0.55893172 |
| 97 | MAPK12 | 0.55326617 |
| 98 | CDK6 | 0.54967992 |
| 99 | DYRK1B | 0.54761849 |
| 100 | CDK4 | 0.53801760 |
| 101 | TAOK3 | 0.52671331 |
| 102 | PTK2B | 0.50402188 |
| 103 | RPS6KA6 | 0.48744005 |
| 104 | PRKCQ | 0.48283022 |
| 105 | MAPK4 | 0.43956554 |
| 106 | MAPK15 | 0.43420141 |
| 107 | CAMK1G | 0.42684184 |
| 108 | STK11 | 0.42213347 |
| 109 | EPHA3 | 0.42210201 |
| 110 | PRKCH | 0.42101136 |
| 111 | STK4 | 0.41876618 |
| 112 | RPS6KC1 | 0.40775006 |
| 113 | RPS6KL1 | 0.40775006 |
| 114 | ALK | 0.40757418 |
| 115 | MST1R | 0.40048653 |
| 116 | SGK3 | 0.38786009 |
| 117 | CDK19 | 0.38555800 |
| 118 | HIPK2 | 0.37557643 |
| 119 | STK38 | 0.36028633 |
| 120 | MAPKAPK2 | 0.35777624 |
| 121 | MAPK11 | 0.35526551 |
| 122 | BMX | 0.35356803 |
| 123 | MAP3K5 | 0.34535821 |
| 124 | CAMKK1 | 0.34159567 |
| 125 | EGFR | 0.31269606 |
| 126 | SIK1 | 0.31079896 |
| 127 | ICK | 0.30727326 |
| 128 | PDGFRB | 0.29245667 |
| 129 | MAPK7 | 0.28576968 |
| 130 | RET | 0.28511056 |
| 131 | PRKD1 | 0.28235119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.66804284 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.00839076 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51991445 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.41305455 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39360513 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.19737655 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12786629 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04543814 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02752146 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00328194 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.98102877 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.93972075 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91779544 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.91088265 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.90064527 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83725546 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76298472 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.69266794 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67603941 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61755036 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60912241 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56365117 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53578574 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50693540 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.45803969 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43126507 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.43097576 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.39139366 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38431121 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.36999213 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36929675 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35494406 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34013550 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.32278152 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28612487 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25381112 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.24910527 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.24617347 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22429994 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22029186 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.18816537 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.15780053 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15584211 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14506123 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12570280 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11351365 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06791719 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.02494471 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02320028 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01829001 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01047572 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99206926 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93495060 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93190347 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92894296 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92476182 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.91636994 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90686402 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90670582 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88553758 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84260164 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.80380923 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80211717 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78388904 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78172163 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75380005 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.75357984 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75054195 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73715411 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73565924 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.73396043 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72667250 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.71003106 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70928603 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.70612979 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69646394 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69280811 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68058809 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67200348 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65028729 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.64895859 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64375035 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.63445512 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63278021 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62108225 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.61924507 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61719024 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.60781913 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59612018 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56192365 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53543673 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52963725 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.52253996 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51537868 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50990923 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50709107 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49351237 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49185801 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49132955 |
| 100 | DNA replication_Homo sapiens_hsa03030 | 0.48841501 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46709190 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46639297 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45586373 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44321114 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43144286 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41399340 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40497677 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39208077 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39177976 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37946925 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37556719 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37095947 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36697060 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35668991 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35209711 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32439965 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31721102 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31118457 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29899913 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29850387 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.27478670 |

